With the advent of combinatorial chemistry and high throughput screening, the number of poorly water soluble drug candidates has dramatically increased. The “drugability” of new chemical entities (NCEs) and life-cycle management of
marketed pharmaceutical products are becoming more challenging.
For more information Click Here
PATHEON